Details for New Drug Application (NDA): 019546
✉ Email this page to a colleague
The generic ingredient in DYNACIRC is isradipine. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the isradipine profile page.
Summary for 019546
Tradename: | DYNACIRC |
Applicant: | Smithkline Beecham |
Ingredient: | isradipine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019546
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 20, 1990 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 20, 1990 | TE: | RLD: | Yes |
Expired US Patents for NDA 019546
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-001 | Dec 20, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-002 | Dec 20, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription